Endothelin antagonism reduces hemoglobin A1c in patients with pulmonary hypertension.
Saved in:
| Title: | Endothelin antagonism reduces hemoglobin A1c in patients with pulmonary hypertension. |
|---|---|
| Authors: | Stapel JR; Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, MS 39216, USA., Speed JS; Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, MS 39216, USA., Clemmer JS; Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, MS 39216, USA. |
| Source: | Canadian journal of physiology and pharmacology [Can J Physiol Pharmacol] 2022 Aug 01; Vol. 100 (8), pp. 828-833. Date of Electronic Publication: 2022 Jun 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Canadian Science Publishing Country of Publication: Canada NLM ID: 0372712 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1205-7541 (Electronic) Linking ISSN: 00084212 NLM ISO Abbreviation: Can J Physiol Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1205-7541 |
|---|---|
| DOI: | 10.1139/cjpp-2022-0132 |
